the key take away is - have a look at who is doing the DD. this is significant progress in my opinion. the life sciences team at KYOCERA have been given a mandate and a choice and they have chosen Leo and RGS.
yes they maybe getting a good deal, but to a company as large as Kyocera have plenty of cash, it's more reputation than the $$$, they are diversifying into an area they see growth, they have a clear strategy and RGS will be going along for the ride.
this is a bolt on acquisition if I ever saw one, it just comes down to price. I reckon that price will be ~$1.00
Leo is adamant RGS have superior technology in the market, next deal Leo signs will be reflected in the upfront!
the key take away is - have a look at who is doing the DD. this...
-
- There are more pages in this discussion • 21 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
